The discipline of pharmacology rests on two fundamental pillars: pharmacodynamics (PD) and pharmacokinetics (PK). These two concepts describe the dual, reciprocal relationship between a drug and the body, providing the quantitative framework for understanding and predicting drug action.
Scientists search for specific biological structures—usually proteins, receptors, or genes—associated with a disease. Pharmacology validates these targets by proving that altering their activity will produce a therapeutic benefit. High-Throughput Screening (HTS)
Pharmacology is the scientific cornerstone of the drug discovery and development process. It serves as the bridge between basic laboratory research and the delivery of safe, effective medicines to patients. By studying how chemical substances interact with living systems, pharmacologists determine which molecules have the potential to treat diseases and, crucially, which do not. 1. The Role of Pharmacology in Early Discovery pharmacology in drug discovery and development
Once in humans, pharmacology runs the show.
PK tracks the life cycle of a compound within the system. It is commonly summarized by the acronym ADME : Absorption: How the drug enters the bloodstream. Distribution: How it travels to various tissues and organs. The discipline of pharmacology rests on two fundamental
, researchers prove that hitting this target will actually slow or stop the disease. Hit-to-Lead:
The entire process begins with choosing a biological target to be modulated for therapeutic effect. Pharmacology plays a pivotal role here. Through basic research, pharmacologists help identify a specific gene, protein, or pathway that is implicated in a disease. Target validation then involves demonstrating that modulating this target is likely to produce a therapeutic benefit. Clinical pharmacologists and basic scientists work together, using their expertise to develop hypotheses and design experiments that solidify the evidence for a target's role. A target might be validated by showing its overexpression in diseased tissue, or by using genetic tools to "knock it out" in animal models. By studying how chemical substances interact with living
Testing begins in vitro (using cell cultures or isolated tissues) and progresses to in vivo (using animal models) to evaluate how the drug behaves in a living, complex organism.
💡 Success depends on balancing Potency (how strong it is) with Bioavailability (how much actually reaches the target). If you'd like to dive deeper, let me know: